These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9795767)
21. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Robinson AP; Harp CT; Noronha A; Miller SD Handb Clin Neurol; 2014; 122():173-89. PubMed ID: 24507518 [TBL] [Abstract][Full Text] [Related]
22. Intramolecular epitope spreading induced by staphylococcal enterotoxin superantigen reactivation of experimental allergic encephalomyelitis. Soos JM; Mujtaba MG; Schiffenbauer J; Torres BA; Johnson HM J Neuroimmunol; 2002 Feb; 123(1-2):30-4. PubMed ID: 11880146 [TBL] [Abstract][Full Text] [Related]
23. Use of reinduced experimental autoimmune encephalomyelitis to evaluate the importance of epitope spread. Lindsey JW Int Immunol; 1998 Jun; 10(6):743-8. PubMed ID: 9678754 [TBL] [Abstract][Full Text] [Related]
24. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. Zhong MC; Kerlero de Rosbo N; Ben-Nun A J Clin Invest; 2002 Jul; 110(1):81-90. PubMed ID: 12093891 [TBL] [Abstract][Full Text] [Related]
25. 'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides. Kaushansky N; Kerlero de Rosbo N; Zilkha-Falb R; Yosef-Hemo R; Cohen L; Ben-Nun A PLoS One; 2011; 6(11):e27860. PubMed ID: 22140475 [TBL] [Abstract][Full Text] [Related]
26. Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease. Yin L; Yu M; Edling AE; Kawczak JA; Mathisen PM; Nanavati T; Johnson JM; Tuohy VK J Immunol; 2001 Dec; 167(11):6105-12. PubMed ID: 11714769 [TBL] [Abstract][Full Text] [Related]
27. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis]. Rodríguez-Rodríguez Y; Suárez-Luis I Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047 [TBL] [Abstract][Full Text] [Related]
28. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. Smith CE; Miller SD J Autoimmun; 2006 Dec; 27(4):218-31. PubMed ID: 17289470 [TBL] [Abstract][Full Text] [Related]
29. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Takács K; Chandler P; Altmann DM Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820 [TBL] [Abstract][Full Text] [Related]
30. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease. Neville KL; Dal Canto MC; Bluestone JA; Miller SD J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534 [TBL] [Abstract][Full Text] [Related]
31. A human leucocyte antigen-DR1 transgene confers susceptibility to experimental allergic encephalomyelitis elicited by an epitope of myelin basic protein. Sireci G; Dieli F; Caccamo N; Barera A; Carta P; Di Sano C; Meraviglia S; Bonanno CT; Salerno A Scand J Immunol; 2003 Aug; 58(2):188-94. PubMed ID: 12869140 [TBL] [Abstract][Full Text] [Related]
32. Determinant spreading during experimental autoimmune encephalomyelitis: is it potentiating, protecting or participating in the disease? Kumar V Immunol Rev; 1998 Aug; 164():73-80. PubMed ID: 9795765 [TBL] [Abstract][Full Text] [Related]
33. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells. Zamvil SS; Mitchell DJ; Powell MB; Sakai K; Rothbard JB; Steinman L J Exp Med; 1988 Sep; 168(3):1181-6. PubMed ID: 2459291 [TBL] [Abstract][Full Text] [Related]
35. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367 [TBL] [Abstract][Full Text] [Related]
36. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Mendel I; Kerlero de Rosbo N; Ben-Nun A Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871 [TBL] [Abstract][Full Text] [Related]
37. Neonatal injection of Lewis rats with recombinant V beta 8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis. Vainiene M; Burrows GG; Ariail K; Robey I; Vandenbark AA; Offner H J Neurosci Res; 1996 Aug; 45(4):475-86. PubMed ID: 8872909 [TBL] [Abstract][Full Text] [Related]
38. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. Smith PA; Morris-Downes M; Heijmans N; Pryce G; Arter E; O'Neill JK; 't Hart B; Baker D; Amor S J Neuroimmunol; 2005 Jul; 164(1-2):76-84. PubMed ID: 15927270 [TBL] [Abstract][Full Text] [Related]
39. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Mendel Kerlero de Rosbo N; Ben-Nun A Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962 [TBL] [Abstract][Full Text] [Related]
40. A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data? Vaughan K; Peters B; O'Connor KC; Martin R; Sette A J Neuroimmunol; 2014 Feb; 267(1-2):73-85. PubMed ID: 24365494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]